Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126.

Int J Radiat Oncol Biol Phys. 2022 Jan 1;112(1):83-92.

Více informací ZDE 

Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2).

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):536-545.

Více informací ZDE 

Results from a prospective, randomised study on (accelerated) preoperative versus (conventional) postoperative radiotherapy in treatment of patients with resectable squamous cell carcinoma of the oral cavity - The ARTSCAN 2 study.

Radiother Oncol. 2022 Jan;166:26-32.

Více informací ZDE 

Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial.

Lancet Oncol. 2022 Jan;23(1):104-114.

Více informací ZDE 

Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.

Lancet. 2022 Jan 29;399(10323):447-460.

Více informací ZDE 

Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy.

Int J Radiat Oncol Biol Phys. 2022 Feb 1;112(2):390-399.

Více informací ZDE 

Parotid Gland Stem Cell Sparing Radiation Therapy for Patients With Head and Neck Cancer: A Double-Blind Randomized Controlled Trial.

Int J Radiat Oncol Biol Phys. 2022 Feb 1;112(2):306-316.

Více informací ZDE 

Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial.

Int J Radiat Oncol Biol Phys. 2022 Feb 1;112(2):294-303.

Více informací ZDE 

Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial.

Lancet Oncol. 2022 Feb;23(2):259-269.

Více informací ZDE 

Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial.

Lancet Oncol. 2022 Feb;23(2):220-233.

Více informací ZDE 

Randomized Phase 3, Double-Blind, Placebo-Controlled Study of Prophylactic Gabapentin for the Reduction of Oral Mucositis Pain During the Treatment of Oropharyngeal Squamous Cell Carcinoma.

Int J Radiat Oncol Biol Phys. 2022 Mar 15;112(4):926-937.

Více informací ZDE 

Patient-Reported Outcomes in the Acute Phase of the Randomized Hypofractionated Irradiation for Prostate Cancer (HYPRO) Trial.

Int J Radiat Oncol Biol Phys. 2022 Mar 15;112(4):870-879.

Více informací ZDE 

Association of Short-Term Patient-Reported Outcomes With Long-Term Oncologic Outcomes in Localized Prostate Cancer Patients Treated With Radiation Therapy and Androgen Deprivation Therapy in a Randomized Controlled Trial.

Int J Radiat Oncol Biol Phys. 2022 Mar 15;112(4):880-889.

Více informací ZDE 

Impact of Dose-Escalated Chemoradiation on Quality of Life in Patients With Locally Advanced Rectal Cancer: 2-Year Follow-Up of the Randomized RECTAL-BOOST Trial.

Int J Radiat Oncol Biol Phys. 2022 Mar 1;112(3):694-703.

Více informací ZDE 

Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer.

N Engl J Med. 2022 Mar 10;386(10):923-932.

Více informací ZDE 

Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial.

J Clin Oncol. 2022 Mar 10;40(8):866-875.

Více informací ZDE 

Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108)

J Clin Oncol. 2022 Mar 20;40(9):978-987.

Více informací ZDE 

Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical Trial.

JAMA Oncol. 2022 Apr 1;8(4):546-552.

Více informací ZDE 

Palliative Radiation for Advanced Central Lung Tumors With Intentional Avoidance of the Esophagus (PROACTIVE): A Phase 3 Randomized Clinical Trial.

JAMA Oncol. 2022 Apr 1;8(4):1-7.

Více informací ZDE 

Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.

J Clin Oncol. 2022 Apr 20;40(12):1301-1311.

Více informací ZDE 

Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial.

J Clin Oncol. 2022 Apr 10;40(11):1220-1230.

Více informací ZDE 

Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial.

Lancet Oncol. 2022 Apr;23(4):479-490.

Více informací ZDE 

Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial.

Lancet Oncol. 2022 Apr;23(4):501-513.

Více informací ZDE 

High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial.

Lancet Oncol. 2022 May;23(5):671-681.

Více informací ZDE 

Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR).

J Clin Oncol. 2022 May 20;40(15):1681-1692.

Více informací ZDE 

Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial.

JAMA Oncol. 2022 May 1;8(5):706-714.

Více informací ZDE 

Diffusion-Weighted Magnetic Resonance Imaging-Guided Dose Painting in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy Plus Concurrent Chemoradiotherapy: A Randomized, Controlled Clinical Trial.

Int J Radiat Oncol Biol Phys. 2022 May 1;113(1):101-113.

Více informací ZDE 

Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the Danish breast cancer cooperative group DBCG 82bc trial.

Radiother Oncol. 2022 May;170:4-13.

Více informací ZDE 

The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.

Lancet. 2022 May 14;399(10338):1886-1901.

Více informací ZDE 

Prophylactic Use of Compression Sleeves Reduces the Incidence of Arm Swelling in Women at High Risk of Breast Cancer-Related Lymphedema: A Randomized Controlled Trial.

J Clin Oncol. 2022 Jun 20;40(18):2004-2012.

Více informací ZDE 

Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial.

J Clin Oncol. 2022 Jun 20;40(18):1980-1990.

Více informací ZDE 

Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial.

JAMA Oncol. 2022 Jun 1;8(6):1-7.

Více informací ZDE 

Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - The RAPIDO trial.

Radiother Oncol. 2022 Jun;171:69-76.

Více informací ZDE 

Effect of Supine vs Prone Breast Radiotherapy on Acute Toxic Effects of the Skin Among Women With Large Breast Size: A Randomized Clinical Trial.

JAMA Oncol. 2022 Jul 1;8(7):994-1000.

Více informací ZDE 

Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centres.

Radiother Oncol. 2022 Jul;172:32-41.

Více informací ZDE 

The association of internal mammary and medial supraclavicular lymph node radiation technique with clinical outcomes: Results from the EORTC 22922/10925 randomised trial.

Radiother Oncol. 2022 Jul;172:99-110.

Více informací ZDE 

Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical Trial.

JAMA. 2022 Aug 23;328(8):728-736.

Více informací ZDE 

Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.

Lancet. 2022 Aug 6;400(10350):431-440.

Více informací ZDE 

Radiation Therapy Dose Escalation in Unresectable Ewing Sarcoma: Final Results of a Phase 3 Randomized Controlled Trial.

Int J Radiat Oncol Biol Phys. 2022 Aug 1;113(5):996-1002.

Více informací ZDE 

Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors.

J Clin Oncol. 2022 Aug 10;40(23):2539-2545.

Více informací ZDE 

Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial.

J Clin Oncol. 2022 Aug 1;40(22):2420-2425.

Více informací ZDE 

Acute Toxicity of Ultrahypofractionation Compared With Moderate Hypofractionation in Prostate Cancer Treatment: A Randomized Trial.

Int J Radiat Oncol Biol Phys. 2022 Aug 1;113(5):1036-1043.

Více informací ZDE 

Randomized Trial of Conventional Versus Conventional Plus Fluciclovine (18F) Positron Emission Tomography/Computed Tomography-Guided Postprostatectomy Radiation Therapy for Prostate Cancer: Volumetric and Patient-Reported Analyses of Toxic Effects.

Int J Radiat Oncol Biol Phys. 2022 Aug 1;113(5):1003-1014.

Více informací ZDE 

Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-yr Follow-up of the Phase 3 Randomised Controlled BC2001 Trial.

Eur Urol. 2022 Sep;82(3):273-279.

Více informací ZDE 

Intensity-Modulated Radiation Therapy Reduces Patient-Reported Chronic Toxicity Compared With Conventional Pelvic Radiation Therapy: Updated Results of a Phase III Trial.

J Clin Oncol. 2022 Sep 20;40(27):3115-3119.

Více informací ZDE 

1